Wednesday, August 30, 2017

Treatment of Lyme Disease Depends on its Autoimmune Response

Researchers at Massachusetts General Hospital are studying whether it is helpful to add disease-altering drugs such as those used to treat rheumatoid arthritis to antibiotics first line to treat Lyme disease.  Side effects are of some concern.  A much safer and less expensive way to treat the secondary autoimmune response of Lyme is low-dose immunotherapy (LDI).

See the American Academy of Environmental Medicine, especially the work of Ty Vincent.


 

No comments: